Berenberg raises Neste stock price target on renewable fuel demand
Source: Investing.com

Berenberg raised Neste's price target to €40 from €36 and maintained a Buy rating, increasing its 2027 earnings estimates by 44% on expectations that renewable-fuels demand will exceed supply. The firm cites EU RED III-driven demand growth, U.S. 2026 biomass-based diesel targets more than 60% higher year over year, and fewer than 5 million tonnes of financed capacity additions beyond 2026. Neste's Q2 2026 EPS of €0.5629 narrowly missed forecasts and revenue of €6.81 billion missed the €7.20 billion consensus by 5.42%, although comparable EBITDA reached a record €1.2 billion.
Analysis
The investable issue is not demand visibility but capture: Neste’s earnings torque depends on the renewable-product spread net of waste-oil/feedstock costs, RIN/LCFS economics, and plant utilization. A tighter market can expand headline product premiums while leaving EBITDA flat if used-cooking-oil and tallow prices re-rate alongside them; this is the key variable to monitor in the next two quarters rather than sell-side 2027 estimates. The OTC ADR is also a poor vehicle for size given liquidity and FX translation; Helsinki-listed NESTE is the cleaner expression.
The market may be underpricing the differentiation between renewable diesel and SAF. Mandate-driven diesel demand is more vulnerable to credit-price volatility and waiver/policy adjustments, whereas airline decarbonization creates a potentially higher-margin, longer-duration outlet if physical supply remains constrained. Conversely, major integrated competitors such as TTE, ENI and CVX-backed renewable diesel capacity have diversified balance sheets and can tolerate lower returns longer than a specialist, limiting the durability of any scarcity premium.
Near term, the share price already embeds a favorable margin backdrop, so upside requires management to convert high realized margins into forward utilization guidance and sustained feedstock discipline. Over 1-3 months, quarterly margin disclosure, RIN/LCFS pricing, and any evidence that new capacity is delayed are catalysts; over 6-18 months, European implementation details and SAF contract pricing determine whether the multiple can remain elevated. Thesis failure would be a sequential decline in renewable-products margin, utilization below guidance, or a material fall in diesel-linked crack spreads without offsetting renewable credit strength.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.38
Ticker Sentiment
Key Decisions for Investors
- Do not chase NESTE/NTOIY at the current high; establish a watch entry only after a 10-15% pullback or following results that confirm sequential renewable-products margin expansion and maintained utilization guidance. Target a 15-25% upside over 6-12 months; exit on two consecutive quarters of margin deterioration.
- For European exposure, prefer a modest long NESTE versus short TTE as a 6-12 month relative-value trade only if renewable margins decouple positively from conventional refining margins. The pair isolates premium renewable-fuel economics, but cut the position if crude-driven refining strength remains the dominant share-price driver.
- Monitor UCO/tallow benchmarks, US D4 RINs, California LCFS credits, and renewable diesel crack spreads weekly. A simultaneous rise in feedstock costs and decline in credit values is a no-go signal even if spot diesel remains elevated.
- Use the next earnings release as the primary catalyst gate: add only if management raises or reiterates full-year EBITDA/throughput expectations while explaining that feedstock inflation is being passed through. A revenue miss without a corresponding margin and volume beat should be treated as evidence of weaker demand realization, not dismissed.
More News
- Citi sees oil prices supported by geopolitical risks and demand
- Sterling today: Pound slips as Fed hike bets and UK inflation uptick weigh
- History points to three key takeaways as Fed prepares to hike
- Huntington Bancshares stock falls on lowered guidance outlook
- Cantor Fitzgerald reiterates Overweight on Solid Biosciences stock
- Piper Sandler warns on equity exposure as market breadth weakens